Opexa Therapeutics, Inc. , a biotechnology company developing Tcelnaa , a novel T-cell therapy for multiple sclerosis , today announced that Neil K. Warma, President and Chief Executive Officer, will present at The Second International Vatican Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science & Culture, taking place ... (more)
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130404005285&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130404005285&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment